LIVE vs VRTX · rev $472.8M vs P/E 30, rev $12.00B
Live Ventures Inc (LIVE) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Live Ventures Inc (LIVE) is a home improvement retail company listed on NASDAQ.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported LIVE revenue for 2024-09-30 was $472.8M. Net income was -$26.7M. Revenue was up 33.1% from 2023-09-30 to 2024-09-30. LIVE currently screens at market cap $29.3M.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
LIVE currently screens at market cap $29.3M. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the LIVE and VRTX stock pages for the full models.
Not investment advice.